TSEACTransmissible Spongiform Encephalopathies Advisory Committee
References in periodicals archive ?
* The TSEAC reviews and evaluates data concerning the safety of products that may be at risk for transmission of spongiform encephalopathies having an impact on the public health.
In 1997, the Food and Drug Administration's Transmissible Spongiform Encephalopathy Advisory Committee (TSEAC) recognized that the use of human dura mater in the United States carries an inherent risk for transmitting CJD.
He serves as consultant to the European CJD surveillance program and as Chair of TSEAC, the transmissible spongiform encephalopathy advisory committee of the United States Food and Drug Administration.